Ophthalmo-acromelic syndrome in a Turkish infant: Case report
East African Medical Journal · 01.06.2002 · 79 (6)
DOI: 10.4314/eamj.v79i6.8856 ↗Kurz gefasst
Fallbericht in der Zeitschrift East African Medical Journal, online erschienen am 01.06.2002. Verfasst von H Caksen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Yüzüncü Yil University, Faculty of Medicine, Van, Turkey. Die Arbeit wurde bisher 7-mal zitiert (Crossref).
Abstract (Originalsprache)
Ophthalmo-acromelic syndrome (OAS) is an extremely rare autosomal recessive disorder characterised by eye malformations ranging from true anophthalmia to mild microophthalmia and acromelic malformations. In this article, we report a newborn infant with OAS because of its rare presentation. He was the fourth sibling affected in the family. The parents were healthy but there was a close blood relationship between the parents. Physical examination revealed bilateral true anophthalmia and oligodactyly (bilateral four toes) on the feet. He had no other additional abnormalities. We consider that this rare syndrome could be relatively more common in our country because six Turkish cases of OAS have been reported in the English literature to date.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Yüzüncü Yil University, Faculty of Medicine, Van, Turkey.
Zitieren
APA
Caksen, H., Odabas, D., Oner, A. F., Abuhandan, M., & Calebi, V. (2002). Ophthalmo-acromelic syndrome in a Turkish infant: Case report. East African Medical Journal, 79(6). https://doi.org/10.4314/eamj.v79i6.8856
Vancouver
Caksen H, Odabas D, Oner AF, Abuhandan M, Calebi V. Ophthalmo-acromelic syndrome in a Turkish infant: Case report. East African Medical Journal. 2002;79(6). doi:10.4314/eamj.v79i6.8856
BibTeX
@article{Caksen2002,
author = {Caksen, H and Odabas, D and Oner, A F and Abuhandan, M and Calebi, V},
title = {Ophthalmo-acromelic syndrome in a Turkish infant: Case report},
journal = {East African Medical Journal},
year = {2002},
volume = {79},
number = {6},
doi = {10.4314/eamj.v79i6.8856}
}
EUVIMED